The global women’s health devices market size is valued at approximately USD 39.27 billion in 2025, and reaching around USD 82.03 billion by 2034, with a robust CAGR of 8.51% over the forecast period. This expansion is driven by rising awareness of women-specific health concerns (like cancers, reproductive issues, menopause), increased healthcare expenditure, advanced diagnostics and wearable device adoption, and strong R&D activity across the sector.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Women’s Health Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Women’s Health Devices Market, by Product Type
8.1.1. Surgical
8.1.1.1. Market Revenue and Forecast
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast
8.1.3. Contraceptives
8.1.3.1. Market Revenue and Forecast
8.1.4. Labor & Delivery
8.1.4.1. Market Revenue and Forecast
8.1.5. Critical Care
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Women’s Health Devices Market, by Type
9.1.1. Devices
9.1.1.1. Market Revenue and Forecast
9.1.2. Consumables
9.1.2.1. Market Revenue and Forecast
10.1. Women’s Health Devices Market, by Application Type
10.1.1. Chronic Diseases
10.1.1.1. Market Revenue and Forecast
10.1.2. General Health
10.1.2.1. Market Revenue and Forecast
10.1.3. Reproductive Health
10.1.3.1. Market Revenue and Forecast
10.1.4. Pelvic & Uterine Health
10.1.4.1. Market Revenue and Forecast
10.1.5. Cancer
10.1.5.1. Market Revenue and Forecast
10.1.6. Infectious Disease
10.1.6.1. Market Revenue and Forecast
10.1.7. Uterine Fibroids
10.1.7.1. Market Revenue and Forecast
10.1.8. Others
10.1.8.1. Market Revenue and Forecast
11.1. Women’s Health Devices Market, by End User Type
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Home Healthcare
11.1.2.1. Market Revenue and Forecast
11.1.3. Obstetrics & Gynecology Clinics
11.1.3.1. Market Revenue and Forecast
11.1.4. Diagnostic Laboratories
11.1.4.1. Market Revenue and Forecast
11.1.5. Ambulatory Surgical Centers
11.1.5.1. Market Revenue and Forecast
11.1.6. Others
11.1.6.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product
12.1.2. Market Revenue and Forecast, by Type
12.1.3. Market Revenue and Forecast, by Application Type
12.1.4. Market Revenue and Forecast, by End User Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product
12.1.5.2. Market Revenue and Forecast, by Type
12.1.5.3. Market Revenue and Forecast, by Application Type
12.1.5.4. Market Revenue and Forecast, by End User Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product
12.1.6.2. Market Revenue and Forecast, by Type
12.1.6.3. Market Revenue and Forecast, by Application Type
12.1.6.4. Market Revenue and Forecast, by End User Type
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product
12.2.2. Market Revenue and Forecast, by Type
12.2.3. Market Revenue and Forecast, by Application Type
12.2.4. Market Revenue and Forecast, by End User Type
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product
12.2.5.2. Market Revenue and Forecast, by Type
12.2.5.3. Market Revenue and Forecast, by Application Type
12.2.5.4. Market Revenue and Forecast, by End User Type
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product
12.2.6.2. Market Revenue and Forecast, by Type
12.2.6.3. Market Revenue and Forecast, by Application Type
12.2.6.4. Market Revenue and Forecast, by End User Type
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product
12.2.7.2. Market Revenue and Forecast, by Type
12.2.7.3. Market Revenue and Forecast, by Application Type
12.2.7.4. Market Revenue and Forecast, by End User Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product
12.2.8.2. Market Revenue and Forecast, by Type
12.2.8.3. Market Revenue and Forecast, by Application Type
12.2.8.4. Market Revenue and Forecast, by End User Type
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product
12.3.2. Market Revenue and Forecast, by Type
12.3.3. Market Revenue and Forecast, by Application Type
12.3.4. Market Revenue and Forecast, by End User Type
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product
12.3.5.2. Market Revenue and Forecast, by Type
12.3.5.3. Market Revenue and Forecast, by Application Type
12.3.5.4. Market Revenue and Forecast, by End User Type
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product
12.3.6.2. Market Revenue and Forecast, by Type
12.3.6.3. Market Revenue and Forecast, by Application Type
12.3.6.4. Market Revenue and Forecast, by End User Type
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product
12.3.7.2. Market Revenue and Forecast, by Type
12.3.7.3. Market Revenue and Forecast, by Application Type
12.3.7.4. Market Revenue and Forecast, by End User Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product
12.3.8.2. Market Revenue and Forecast, by Type
12.3.8.3. Market Revenue and Forecast, by Application Type
12.3.8.4. Market Revenue and Forecast, by End User Type
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product
12.4.2. Market Revenue and Forecast, by Type
12.4.3. Market Revenue and Forecast, by Application Type
12.4.4. Market Revenue and Forecast, by End User Type
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product
12.4.5.2. Market Revenue and Forecast, by Type
12.4.5.3. Market Revenue and Forecast, by Application Type
12.4.5.4. Market Revenue and Forecast, by End User Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product
12.4.6.2. Market Revenue and Forecast, by Type
12.4.6.3. Market Revenue and Forecast, by Application Type
12.4.6.4. Market Revenue and Forecast, by End User Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product
12.4.7.2. Market Revenue and Forecast, by Type
12.4.7.3. Market Revenue and Forecast, by Application Type
12.4.7.4. Market Revenue and Forecast, by End User Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product
12.4.8.2. Market Revenue and Forecast, by Type
12.4.8.3. Market Revenue and Forecast, by Application Type
12.4.8.4. Market Revenue and Forecast, by End User Type
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product
12.5.2. Market Revenue and Forecast, by Type
12.5.3. Market Revenue and Forecast, by Application Type
12.5.4. Market Revenue and Forecast, by End User Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product
12.5.5.2. Market Revenue and Forecast, by Type
12.5.5.3. Market Revenue and Forecast, by Application Type
12.5.5.4. Market Revenue and Forecast, by End User Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product
12.5.6.2. Market Revenue and Forecast, by Type
12.5.6.3. Market Revenue and Forecast, by Application Type
12.5.6.4. Market Revenue and Forecast, by End User Type
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hologic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Koninklijke Philips
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Prestige Consumer Healthcare, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott Laboratories
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Caldera Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. MedGyn Products
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medline Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Carestream Health
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description